Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12115811rdf:typepubmed:Citationlld:pubmed
pubmed-article:12115811lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:12115811lifeskim:mentionsumls-concept:C0029224lld:lifeskim
pubmed-article:12115811lifeskim:mentionsumls-concept:C0037628lld:lifeskim
pubmed-article:12115811lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:12115811lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:12115811lifeskim:mentionsumls-concept:C0599956lld:lifeskim
pubmed-article:12115811pubmed:issue8lld:pubmed
pubmed-article:12115811pubmed:dateCreated2002-7-12lld:pubmed
pubmed-article:12115811pubmed:abstractTextA quantitative structure-property relationship (QSPR) was developed for predicting the aqueous solubility of drug-like compounds from their chemical structures. A set of 321 structurally diverse drugs or related compounds, with their intrinsic aqueous solubility collected from literature, was used in this analysis. The data were divided into a training set (n = 267) for building the model and a randomly chosen testing set (n = 54) for assessing the predictive ability of the model. A series of molecular descriptors was calculated directly from chemical structures and a set of eight descriptors, including dipole moment, surface area, volume, molecular weight, number of rotatable bonds/total bonds, number of hydrogen-bond acceptors, number of hydrogen-bond donors and density, was chosen for the final model. The eight-descriptor model generated by multiple linear regression was further optimized by a genetic algorithm guided selection method. The model has a correlation coefficient (r) of 0.95 and a root-mean-square (rms) error of 0.56 log unit. It predicts the solubility of testing set compounds with a reasonable degree of accuracy (r = 0.84 and rms = 0.86 log unit). The present model can serve as a tool for medicinal chemists to guide their early synthetic efforts in arriving at appropriate analogs.lld:pubmed
pubmed-article:12115811pubmed:languageenglld:pubmed
pubmed-article:12115811pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12115811pubmed:citationSubsetIMlld:pubmed
pubmed-article:12115811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12115811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12115811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12115811pubmed:statusMEDLINElld:pubmed
pubmed-article:12115811pubmed:monthAuglld:pubmed
pubmed-article:12115811pubmed:issn0022-3549lld:pubmed
pubmed-article:12115811pubmed:authorpubmed-author:LiYiYlld:pubmed
pubmed-article:12115811pubmed:authorpubmed-author:ChoSung JinSJlld:pubmed
pubmed-article:12115811pubmed:authorpubmed-author:ChenXue-QingX...lld:pubmed
pubmed-article:12115811pubmed:authorpubmed-author:VenkateshSrin...lld:pubmed
pubmed-article:12115811pubmed:copyrightInfoCopyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Associationlld:pubmed
pubmed-article:12115811pubmed:issnTypePrintlld:pubmed
pubmed-article:12115811pubmed:volume91lld:pubmed
pubmed-article:12115811pubmed:ownerNLMlld:pubmed
pubmed-article:12115811pubmed:authorsCompleteYlld:pubmed
pubmed-article:12115811pubmed:pagination1838-52lld:pubmed
pubmed-article:12115811pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:meshHeadingpubmed-meshheading:12115811...lld:pubmed
pubmed-article:12115811pubmed:year2002lld:pubmed
pubmed-article:12115811pubmed:articleTitlePrediction of aqueous solubility of organic compounds using a quantitative structure-property relationship.lld:pubmed
pubmed-article:12115811pubmed:affiliationDiscovery Pharmaceutics, L12-09, Preclinical Candidate Optimization, Bristol-Myers Squibb Pharmaceutical Research Institute, Lawrenceville, New Jersey 08543, USA.lld:pubmed
pubmed-article:12115811pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12115811lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12115811lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12115811lld:pubmed